Recently, remarkable developments have been seen in bladder cancer research and treatment. We have seen some amazing advances in genomics and molecular biology that apply precision medicine strategies for diagnosis and treatment of bladder cancer using molecular classification.
Editorial on Muscle-invasive Bladder Cancer
Where are we now and where are we heading in muscle invasive bladder cancer
Review Article on Muscle-invasive Bladder Cancer
Tumor heterogeneity in muscle-invasive bladder cancer
Update on bladder cancer molecular subtypes
Role of magnetic resonance imaging in tumor staging and follow-up for bladder cancer
Role of PET/CT in muscle-invasive bladder cancer
Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer
Partial cystectomy for muscle-invasive bladder cancer: a review of the literature
Review of the evidence for robotic-assisted robotic cystectomy and intra-corporeal urinary diversion in bladder cancer
Is there an oncological benefit to extended lymphadenectomy for muscle-invasive bladder cancer?
The optimal management of variant histology in muscle invasive bladder cancer
Perioperative immunotherapy for muscle-invasive bladder cancer
Enhanced recovery after surgery of patients undergoing radical cystectomy for bladder cancer
Health-related quality of life after radical cystectomy
Disclosure:
The series “Muscle-invasive Bladder Cancer” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Drs. Ja Hyeon Ku, Ho Kyung Seo and Seok Ho Kang served as the unpaid Guest Editors for the series.